These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 1833421

  • 1. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW.
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [Abstract] [Full Text] [Related]

  • 2. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW.
    Agents Actions Suppl; 1992 Oct; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay.
    Levi M, de Boer JP, Roem D, ten Cate JW, Hack CE.
    Thromb Haemost; 1992 Jan 23; 67(1):111-6. PubMed ID: 1377412
    [Abstract] [Full Text] [Related]

  • 4. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C, Trumpi-Kalshoven MM, Jie AF, Veldhuyzen-Stolk EC.
    Thromb Haemost; 1979 Jun 30; 41(4):756-73. PubMed ID: 483248
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 30; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 6. DDAVP induces systemic release of urokinase-type plasminogen activator.
    Levi M, ten Cate JW, Dooijewaard G, Sturk A, Brommer EJ, Agnelli G.
    Thromb Haemost; 1989 Sep 29; 62(2):686-9. PubMed ID: 2510348
    [Abstract] [Full Text] [Related]

  • 7. Homozygous type I plasminogen deficiency.
    Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V.
    Semin Thromb Hemost; 1997 Sep 29; 23(3):259-69. PubMed ID: 9255907
    [Abstract] [Full Text] [Related]

  • 8. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F, Castaman G, Ruggeri M, Cazzavillan M, Ferracin G, Dini E.
    Haematologica; 1991 Sep 29; 76(1):28-32. PubMed ID: 2055558
    [Abstract] [Full Text] [Related]

  • 9. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P, de Boer A, Verstreken M, Collen D.
    Thromb Haemost; 1986 Oct 21; 56(2):124-7. PubMed ID: 2433784
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep 21; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 11. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ, Dooijewaard G, Turion PN.
    Thromb Haemost; 1991 Feb 12; 65(2):144-8. PubMed ID: 1905069
    [Abstract] [Full Text] [Related]

  • 12. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F, Aznar J, Estelles A.
    J Lab Clin Med; 1982 Nov 12; 100(5):756-70. PubMed ID: 6182261
    [Abstract] [Full Text] [Related]

  • 13. Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patients.
    Brommer EJ, Schicht I, Wijngaards G, Verheijen JH, Rijken DC.
    Thromb Haemost; 1984 Dec 29; 52(3):311-4. PubMed ID: 6085194
    [Abstract] [Full Text] [Related]

  • 14. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR.
    Behring Inst Mitt; 1983 Aug 29; (73):43-55. PubMed ID: 6236789
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
    MacGregor IR, Roberts EM, Prowse CV, Broomhead AF, Ozolins M, Litka P.
    Thromb Haemost; 1988 Feb 25; 59(1):34-9. PubMed ID: 3129807
    [Abstract] [Full Text] [Related]

  • 17. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
    Bykowska K, Letowska M, Sabliński J, Binder BR, Kopeć M, Lopaciuk S.
    Acta Haematol Pol; 1994 Feb 25; 25(3):261-8. PubMed ID: 7992599
    [Abstract] [Full Text] [Related]

  • 18. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 25; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 19. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG, Steenwyk BL, Gurley WQ.
    J Heart Lung Transplant; 2006 Oct 25; 25(10):1247-52. PubMed ID: 17045938
    [Abstract] [Full Text] [Related]

  • 20. Elevated plasmin-alpha 2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system.
    Nilsson T, Bäck O.
    Thromb Res; 1985 Dec 15; 40(6):817-21. PubMed ID: 2935973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.